High activity 90Y-ibritumomab tiuxetan (Zevalin) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomas. (Q53518457)
Jump to navigation
Jump to search
scientific article published in November 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High activity 90Y-ibritumomab tiuxetan (Zevalin) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomas. |
scientific article published in November 2007 |
Statements
High activity 90Y-ibritumomab tiuxetan (Zevalin) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomas. (English)
1 reference
1 reference
1 reference
Giovanni Martinelli
1 reference
Anna Vanazzi
1 reference
Chiara M Grana
1 reference
Marta Cremonesi
1 reference
Mirco Bartolomei
1 reference
Marco Chinol
1 reference
Mahila Ferrari
1 reference
Davide Radice
1 reference
Stefano Papi
1 reference
1 November 2007
1 reference
139
1 reference
4
1 reference
590-599
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference